Related Experiment Video
Updated: Sep 28, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)
Muhammed Burak Demircan1,2,3,4, Tina M Schnoeder5, Peter C Mgbecheta3
1Innere Medizin II, Hämatologie und Onkologie, Jena University Hospital, Jena, Germany.
Purpose:
Oxidative stress has been linked to initiation and progression of cancer and recent studies have indicated a potential translational role regarding modulation of ROS in various cancers, including acute myeloid leukemia (AML). Detailed understanding of the complex machinery regulating ROS including its producer elements in cancer is required to define potential translational therapeutic use. Based on previous studies in acute myeloid leukemia (AML) models, we considered NADPH oxidase (NOX) family members, specifically NOX4 as a potential target in AML.
Methods:
Pharmacologic inhibition and genetic inactivation of NOX4 in murine and human models of AML were used to understand its functional role. For genetic inactivation, CRISPR-Cas9 technology was used in human AML cell lines in vitro and genetically engineered knockout mice for Nox4 were used for deletion of Nox4 in hematopoietic cells via Mx1-Cre recombinase activation.
Results:
Pharmacologic NOX inhibitors and CRISPR-Cas9-mediated inactivation of NOX4 and p22-phox (an essential NOX component) decreased proliferative capacity and cell competition in FLT3-ITD-positive human AML cells. In contrast, conditional deletion of Nox4 enhanced the myeloproliferative phenotype of an FLT3-ITD induced knock-in mouse model. Finally, Nox4 inactivation in normal hematopoietic stem and progenitor cells (HSPCs) caused a minor reduction in HSC numbers and reconstitution capacity.
Conclusion:
The role of NOX4 in myeloid malignancies appears highly context-dependent and its inactivation results in either enhancing or inhibitory effects. Therefore, targeting NOX4 in FLT3-ITD positive myeloid malignancies requires additional pre-clinical assessment.
Insights
Targeting NADPH oxidase 4 (NOX4) in acute myeloid leukemia (AML) showed context-dependent effects. In some cases, NOX4 inactivation inhibited cancer cell proliferation, while in others, it enhanced disease progression, necessitating further preclinical evaluation.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Oxidative stress is implicated in cancer development and progression.
- Reactive oxygen species (ROS) modulation is a potential therapeutic strategy in cancers like acute myeloid leukemia (AML).
- NADPH oxidase (NOX) family members are key regulators of ROS production.
Purpose of the Study:
- To investigate the role of NOX4, a specific NADPH oxidase family member, as a potential therapeutic target in AML.
- To understand the complex machinery regulating ROS and its producer elements in AML.
Main Methods:
- Utilized pharmacologic inhibition and genetic inactivation of NOX4 in murine and human AML models.
- Employed CRISPR-Cas9 technology for in vitro genetic inactivation in human AML cell lines.
- Generated genetically engineered knockout mice for Nox4 deletion in hematopoietic cells.
Main Results:
- NOX4 and p22-phox inactivation decreased proliferation in FLT3-ITD-positive AML cells.
- Conditional deletion of Nox4 exacerbated the myeloproliferative phenotype in a FLT3-ITD mouse model.
- Inactivation of NOX4 in normal hematopoietic stem and progenitor cells (HSPCs) led to a minor reduction in HSC numbers and reconstitution capacity.
Conclusions:
- The function of NOX4 in myeloid malignancies is highly context-dependent.
- NOX4 inactivation can have opposing effects, either inhibiting or enhancing disease progression.
- Targeting NOX4 in FLT3-ITD positive myeloid malignancies requires further preclinical investigation.
More Related Videos
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...